The Case Comprehensive Cancer Center is providing funding for Pilot Projects to utilize the newly designated SOM/UH Integrated Microbiome Core (IMC). The IMC offers cutting edge sequencing technology for analysis of the micro- and myco-biomes (16S, ITS, bacterial genomics, metagenomics and metatranscriptomics). Full-service offerings are available including help with experimental design, nucleic acid isolation, generation of genomic data and data analysis.
This RFA is open to all Case CCC Members and applications will be accepted immediately on a rolling basis until all pilot award slots (6) are filled. Proposals cannot be concurrently funded by other sources or by the Cancer Center.
Applications are now open and will remain opene until all projects are awarded.